The Ministry of Social Affairs and Health (hereinafter ‘STM’) and National Institute for Health and Welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is 1 year (during 2019-2020). The extend of the contract (option period) is one year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The customer will choose the supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The tenderer that quoted the lowest reference price per dose will be awarded the contract.

The purpose of STM and the customer is to procure Human Papillomavirus Vaccine (HPV) required for the National Vaccination Programme in Finland. The Customer will implement the procurement on STM's side. The roles of STM and customer are described in more detail in section ‘Presentation of the Contracting Authority’. The subject of procurement and the mandatory requirements relating to it are described in detail in this invitation to tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. Contract period: the contract period is 1 year (during 2019-2020). The contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. Please notice that in the Section ‘II.2.5. Award criteria’ Price means the reference price. Tenders will be compared in the manner described in section ‘Grounds for decision’ of the invitation to tender.